Ray Dalio’s Immunocore IMCR Stock Holding History

Ray Dalio’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	36,707 +17,777	+94%	+$526K	﹤0.01%	812
2026 Q1	$571K	Buy	18,930 +8,978	+90%	+$290K	﹤0.01%	864
2025 Q4	$345K	Buy	+9,952	New	+$351K	﹤0.01%	998

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Ray Dalio's IMCR Position: Q2 2026 in Review

Ray Dalio increased its Immunocore (IMCR) stake by 94% in Q2 2026, buying an estimated $526K and bringing the position to 36,707 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Ray Dalio first reported a position in IMCR in Q4 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Ray Dalio held 36,707 shares of Immunocore worth $1.17M as of Q2 2026.
Ray Dalio bought 17,777 Immunocore shares in Q2 2026, an estimated $526K.
Immunocore made up ﹤0.01% of Ray Dalio's portfolio in Q2 2026, its #812 holding.
Ray Dalio first reported a position in Immunocore in Q4 2025 and has held it in 3 quarters since.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.